3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
3
Other
2
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
398
Leukemia, Myeloid, Acute
387
Leukemia
339
Hematologic Neoplasms
313
Leukemia, Lymphocytic, Chronic, B-Cell
215
Lymphoma
142
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
140
Neoplasms
115
Myelodysplastic Syndromes
108
Multiple Myeloma
98
Lymphoma, Non-Hodgkin
95
Hodgkin Disease
60
Lymphoma, Large B-Cell, Diffuse
56
Lymphoma, Follicular
56
Congenital Abnormalities
52
Lymphoma, Mantle-Cell
49
Burkitt Lymphoma
48
Lymphoma, B-Cell, Marginal Zone
45
Leukemia, Myeloid, Chronic-Phase
45
Myeloproliferative Disorders
42
Leukemia, Myelomonocytic, Chronic
41
Breast Neoplasms
41
Leukemia, Hairy Cell
36
Recurrence
35
Lung Neoplasms
33
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
32
Neoplasms, Plasma Cell
31
Lymphoma, T-Cell, Cutaneous
31
Lymphoma, Large-Cell, Immunoblastic
31
Waldenstrom Macroglobulinemia
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Fecal Incontinence
×
Other hematologic neoplasm
×
Clear all
NCT05621629
2023-04-12
Management of FI After Surgery of ARM
Shengjing Hospital
Completed
108 enrolled